- +1 206 317 1218
- +44 117 3181724
- live:sales_55228
CONSULTING
Serving clients with business strategic moves to gain competitive advantage.
CUSTOMIZED RESEARCH
Providing a wide range of services related to the emerging industry is our prime focus.
SYNDICATE RESEARCH
Provide research study with detailed statistical & in-depth analysis of market trends & dynamics.
Customized Reports
Advance Market Analytics has many Years of experience and specializes in Market Research Industry. In the Market Analysis report we provide you Primary and Secondary Research Study in different domain. You can get the in-depth report worldwide. Click here to check the Segmentation of Customized report
Featured Report
October 22, 2018
222 Pages
In United States, According to the FDA, “Accelerated approval is given to some new drugs for serious and life-threatening illnesses that lack satisfactory treatments. This allows an NDA (new drug application) to be approved before measures of effectiveness that would usually be required for approval are available.”
The article cited AMA's "Global Drug Discovery Technologies Market Study" explored substantial growth in North America and CAGR of 9.96%. According to the report,...
The article cited AMA's "Global Drug Discovery Technologies Market Study" explored substantial growth in North America and CAGR of 9.96%. According to the report,...
August 18, 2018
237 Pages
The federal government’s view of medical marijuana is evolving as the U.S. Food and Drug Administration (“FDA” or “Agency”), on June 25, 2018, approved Epidiolex, the first drug containing cannabidiol (“CBD”), a marijuana derivative, and the U.S. Congress considers several bills aimed at relaxing regulatory standards for medical marijuana. In a press release regarding this recent approval, FDA Commissioner Scott Gottlieb reiterated the Agency’s commitment to “careful scientific research and development,”...
Have a Look!
We bring you a wide array of well researched data and market break down that help gain identify new business segment and opportunities with market scenarios.
